PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas (Q86837798)
Jump to navigation
Jump to search
scientific article published on 01 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
scientific article published on 01 December 2015 |
Statements
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas (English)
Jonathan D Black
Emiliano Cocco
Stefania Bellone
Gary Altwerger
Carlton L Schwab
Diana P English
Federica Predolini
Francesca Ferrari
Elena Ratner
Dan-Arin Silasi
Masoud Azodi
Peter E Schwartz
Alessandro D Santin
1 December 2015